Biocon Biologics gets CDSCO panel nod to import, manufacture Insulin Aspart Injection Dr. Divya Colin25 May 2022 4:23 PM ISTNew Delhi: Approving the waiver of Phase III clinical trial in the country, the Subject Expert Committee (SEC) functional under Central Drug Standard...
Biocon Biologics, Viatris launch cancer medicine Abevmy in Canada Ruchika Sharma20 May 2022 3:02 PM ISTAbevmy is a recombinant humanized monoclonal antibody that selectively binds to human vascular endothelial growth factor (VEGF) and neutralizes its...
Biocon profit declines by 4 percent to Rs 283 crore in Q4 Ruchika Sharma30 April 2022 9:00 AM ISTNew Delhi: Biocon on Thursday reported a 4 per cent decline in consolidated net profit to Rs 283.9 crore in the fourth quarter ended on March 31,...
Biocon profit declines by 4 percent to Rs 283 crore in Q4 Ruchika Sharma30 April 2022 9:00 AM ISTNew Delhi: Biocon on Thursday reported a 4 per cent decline in consolidated net profit to Rs 283.9 crore in the fourth quarter ended on March 31,...
Biocon Biologics bags Rs 689 crore contract for Insugen from Malaysian Govt Ruchika Sharma27 April 2022 2:53 PM ISTThe rh-Insulin formulations, Insugen-R, Insugen-N and lnsugen-30/70, are manufactured at Biocon Sdn. Bhd.'s Johor facility.
Honour- Glasgow University research centre named after Biocon founders Ruchika Sharma30 March 2022 11:42 AM ISTThe USD 7.5 million donation was used to help fund the building of the Mazumdar-Shaw Advanced Research Centre and create a Professorial Chair, the...
Biocon Chief Kiran Mazumdar-Shaw elected as Fellow of Royal Society of Edinburgh Ruchika Sharma25 March 2022 11:45 AM ISTBengaluru: Kiran Mazumdar-Shaw, Executive Chairperson of Biocon and Biocon Biologics, has been elected as the Fellow of the Royal Society of...
Biocon arm to purchase Viatris biosimilars business for USD 3.335 billion MD Bureau28 Feb 2022 1:02 PM ISTBengaluru: Biocon Biologics Ltd., a subsidiary of Biocon Ltd., has announced that the company has entered into a definitive agreement with its partner...
India needs to invest more in research to create better ecosystem: Biocon Chief Kiran Mazumdar-Shaw Ruchika Sharma11 Feb 2022 12:59 PM ISTNew Delhi: India needs to incentivize industries to invest more in academic research for creating a better ecosystem of research and innovation,...
Biocon arm bags USFDA approval for Posaconazole Delayed-Release tablets Ruchika Sharma8 Feb 2022 5:07 PM ISTBangalore: Biocon Pharma Limited, a subsidiary of Biocon Limited, has recently announced that the company has received approval of its...
Biocon, Tabuk Pharma ink pact to commercialise speciality generic drugs in Middle East Ruchika Sharma8 Dec 2021 1:05 PM ISTBengaluru: Biocon Limited has recently announced a partnership with Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary of...
Biocon Mycophenolic Acid gets USFDA okay Ruchika Sharma3 Dec 2021 3:41 PM ISTNew Delhi: Biocon Pharma Limited, a subsidiary of Biocon Limited has received approval from the U S Food and Drug Administration (USFDA) for...
